Comorbidity indexing for prediction of the clinical outcome after stereotactic body radiation therapy in non-small cell lung cancer

PURPOSE: To determine the prognostic impact of comorbidity and age in medically inoperable early-stage non-small cell lung cancer (NSCLC) treated with stereotactic body radiotherapy (SBRT) using the age-adjusted Charlson Comorbidity Index (aCCI). PATIENTS AND METHODS: Between November 2008 and Janua...

Descripción completa

Detalles Bibliográficos
Autores principales: Dreyer, Julia, Bremer, Michael, Henkenberens, Christoph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6215615/
https://www.ncbi.nlm.nih.gov/pubmed/30390700
http://dx.doi.org/10.1186/s13014-018-1156-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6215615/
https://www.ncbi.nlm.nih.gov/pubmed/30390700
http://dx.doi.org/10.1186/s13014-018-1156-1

Ejemplares similares